FuturaGene, the biotechnology arm of Suzano, has received formal regulatory approval from Brazil’s National Biosafety Technical Commission (CTNBio) for its new variety of gene-edited eucalyptus. The approval marks the first time a gene-edited eucalyptus variety has been authorized globally and confirms the variety meets the exemption criteria under Normative Resolution No. 16 (RN 16).
Developed using CRISPR-Cas9, a New Breeding Technique (NBT), the eucalyptus edits are precise and targeted within the genome, introducing no genetic material from other species. The modification is functionally comparable to natural genetic variation or conventional breeding methods. The specific change is designed to improve wood quality by optimizing lignin composition, enabling more sustainable pulping with reduced chemical and energy inputs.
Following the regulatory green light, FuturaGene will conduct controlled field trials across different Brazilian growing conditions, adhering to strict biosafety and governance standards.
“This approval reinforces our track record of responsible innovation and adds gene editing to our portfolio of approved genetically modified eucalyptus varieties,” says company. FuturaGene has now obtained 11 CTNBio approvals for GM eucalyptus traits including yield improvement, herbicide tolerance, and insect resistance.
FuturaGene’s technologies aim to support sustainable production of bio-based products, reduce reliance on fossil fuels, and help commercial tree farming adapt to climate change and resource constraints. The company is a global pioneer in tree biotechnology, developing solutions that increase productivity and resilience in eucalyptus cultivation while promoting ecologically-sound forestry practices.